Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease

Journal of the Neurological Sciences

Volumn 250, Issue 1-2, 2006, Pages 39-44

  Nomura, Takashi ^a,c   Inoue, Yuichi ^b   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

^c National Hospital Organisation Yonago Medical Center   (Japan)

Author keywords

Dopamine agonist; International Restless Legs Syndrome Study Group severity scale of RLS; Parkinson's disease; Periodic limb movements during sleep; Pittsburgh Sleep Quality Index; Restless legs syndrome; Suggested immobilization test

Indexed keywords

AMANTADINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; SELEGILINE; THREO 3,4 DIHYDROXYPHENYLSERINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEGENERATION; DIENCEPHALON; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; FAMILY HISTORY; FEMALE; HUMAN; IDIOPATHIC DISEASE; IMMOBILIZATION; LIMB MOVEMENT; MALE; ONSET AGE; PARKINSON DISEASE; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGE OF ONSET; AGED; AGING; ANTICONVULSANTS; CLONAZEPAM; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FAMILY HEALTH; HUMANS; MIDDLE AGED; NEURAL PATHWAYS; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA; TREATMENT OUTCOME;

EID: 33750505404     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.06.023     Document Type: Article

References (34)

1. Ekbom K.A. Restless legs syndrome. Neurology 10 (1960) 863-873
2. Rothdach A.J., Trenkwalder C., Haberstock J., Keil U., and Berger K. Prevalence and risk factors of RLS in an elderly populations: the MEMO Study. Memory and Morbidity in Augsburg Elderly. Neurology 54 (2000) 1064-1068
3. Lavigne G.J., and Montplaisir J.Y. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 17 (1994) 739-743
4. Chokroverty S., and Jankovic J. Restless legs syndrome: a disease in search of identity. Neurology 52 (1999) 907-910
5. Tan E.K., Seah A., See S.J., Lim E., Wong M.C., and Koh K.K. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 16 (2001) 577-579
6. Ohayon M.M., and Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 53 (2002) 547-554
7. Mizuno S., Miyaoka T., Inagaki T., and Horguchi J. Prevalence of restless legs syndrome in non-institutionalized Japanese elderly. Psychiatry Clin Neurosci 59 (2005) 461-465
8. Ondo W.G., Vuong K.D., and Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59 (2002) 421-424
9. Krishnan P.R., Bhatia M., and Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord 18 (2003) 181-185
10. Tan E.K., Lum S.Y., and Wong M.C. Restless legs syndrome in Parkinson's disease. J Neurol Sci 196 (2002) 33-36
11. Nomura T., Inoue Y., Miyake M., Yasui K., and Nakashima K. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease. Mov Disord 21 (2006) 380-384
12. Littner M.R., Kushida C., Anderson W.M., Bailey D., Berry R.B., Hirshkowitz M., et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 (2004) 557-559
13. Miyasaki J.M., Martin W., Suchowersky O., Weiner W.J., and Lang A.E. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 58 (2002) 11-17
14. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisi J. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 (2003) 101-119
15. Doi Y., Minowa M., Uchiyama M., Okawa M., Kim K., Shibui K., et al. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res 97 (2000) 165-172
16. The International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless leg syndrome. Sleep Med 4 (2003) 121-132
17. Allen R.P., Kushida C.A., and Atkinson M.J. RLS QoL Consortium. Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity. Sleep Med 4 (2003) 133-135
18. Atlas Task Force. Recording and scoring leg movements. Sleep 16 (1993) 748-759
19. Montplaisir J., Boucher S., Nicolas A., Lesperance P., Gosselin A., Rompre P., et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless legs syndrome. Mov Disord 13 (1998) 324-329
20. Folstein M.F., and Luria R. Reliability, validity, and clinical application of the visual analogue mood scale. Psychol Med 3 (1973) 479-486
21. Littner M.R., Kushida C., Anderson W.M., Bailey D., Berry R.B., Hirshkowitz M., et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 (2004) 557-559
22. Ferini-Strambi L., Bonati M.T., Oldani A., Aridon P., Zucconi M., and Casari G. Genetics in restless legs syndrome. Sleep Med 5 (2004) 301-304
23. Wetter T.C., Collado-Seidel V., Pollmacher T., Yassouridis A., and Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 23 (2000) 361-367
24. Scatton B., Dennis T., L'Heureux R., Monfort J.C., Duyckaerts C., Javoy-Agid F., et al. Degeneration of noradrenergic and serotonergic but not dopaminergic neurons in the lumbar spinal cord of parkinsonian patients. Brain Res 380 (1986) 181-185
25. Sofic E., Riederer P., Gsell W., Gavranovic M., Schmidtke A., Jellinger K., et al. Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis. J Neural Transm Park Dis Dement Sect 3 (1991) 133-142
26. Ondo W.G., Dat Vuong K., Khan H., Atassi F., Kwak C., Jankovic J., et al. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 57 (2001) 1392-1396
27. Rye D. Modulation of normal and pathologic motoneuron activity during sleep. In: Chokroverty S., Hening W., and Walters A. (Eds). Sleep and movement disorders (2003), Butterworth-Heinemann, Philadelphia 94-119
28. Ondo W.G., He Y., Rajasekaran S., and Le W.D. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 15 (2000) 154-158
29. Rye D.B. The two faces of Eve: dopamine's modulation of wakefulness and sleep. Neurology 63 (2004) S2-S7
30. Hogl B., Rothdach A., Wetter T.C., and Trenkwalder C. The effect of cabergoline on sleep, periodic movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology 28 (2003) 1866-1870
31. Saletu M., Anderer P., Saletu B., Hauer C., Mandl M., Semler B., et al. Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole. Hum Psychopharmacol 16 (2001) 177-187
32. Saletu M., Anderer P., Saletu-Zuhlarz G., Prause W., Semler B., Zoghlami A., et al. Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 11 (2001) 153-161
33. Trophy M.J. New paradigms in the treatment of restless legs syndrome. Neurology 64 (2005) S28-S33
34. Ondo W.G. Restless legs syndrome. Curr Neurol Neurosci Rep 5 (2005) 266-274